{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T23:09:44Z","timestamp":1789254584443,"version":"build-2803163510"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-02714-4","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T14:21:10Z","timestamp":1745418070000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Innovative PEGylated chitosan nanocarriers for co-delivery of doxorubicin and CpG in breast cancer therapy: Preparation, characterization, and immunotherapeutic potential"],"prefix":"10.1007","volume":"42","author":[{"given":"Sitah","family":"Alharthi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal Abdullah","family":"Alrashidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zyta","family":"Ziora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Ebrahimi Shahmabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Ebrahim","family":"Alavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"key":"2714_CR1","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.semcancer.2020.06.005","volume":"72","author":"F Borri","year":"2021","unstructured":"Borri F, Granaglia A. Pathology of triple negative breast cancer. Semin Cancer Biol. 2021;72:136\u201345. https:\/\/doi.org\/10.1016\/j.semcancer.2020.06.005.","journal-title":"Semin Cancer Biol."},{"issue":"2","key":"2714_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41571-021-00565-2","volume":"19","author":"G Bianchini","year":"2022","unstructured":"Bianchini G, De Angelis C, Licata L, Gianni L. Treatment landscape of triple-negative breast cancer\u2014Expanded options, evolving needs. Nat Rev Clin Oncol. 2022;19(2):91\u2013113. https:\/\/doi.org\/10.1038\/s41571-021-00565-2.","journal-title":"Nat Rev Clin Oncol"},{"key":"2714_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.bioactmat.2023.01.014","volume":"25","author":"B Guo","year":"2023","unstructured":"Guo B, Qu Y, Sun Y, Zhao S, Yuan J, Zhang P, Zhong Z, Meng F. Co-delivery of gemcitabine and paclitaxel plus NanoCpG empowers chemoimmunotherapy of postoperative \u201ccold\u201d triple-negative breast cancer. Bioact Mater. 2023;25:61\u201372. https:\/\/doi.org\/10.1016\/j.bioactmat.2023.01.014.","journal-title":"Bioact Mater."},{"issue":"6","key":"2714_CR4","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/s41577-022-00729-w","volume":"22","author":"K Minton","year":"2022","unstructured":"Minton K. Reservoirs of resistance. Nat Rev Immunol. 2022;22(6):336\u20137. https:\/\/doi.org\/10.1038\/s41577-022-00729-w.","journal-title":"Nat Rev Immunol"},{"key":"2714_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105301","volume":"107","author":"J Liu","year":"2024","unstructured":"Liu J, Bai Y, Li Y, Li X, Luo K. Reprogramming the immunosuppressive tumor microenvironment through nanomedicine: an immunometabolism perspective. EBioMedicine. 2024;107: 105301. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105301.","journal-title":"EBioMedicine"},{"issue":"10","key":"2714_CR6","doi-asserted-by":"publisher","first-page":"4127","DOI":"10.7150\/thno.97768","volume":"14","author":"H Li","year":"2024","unstructured":"Li H, Gong Q, Luo K. Biomarker-driven molecular imaging probes in radiotherapy. Theranostics. 2024;14(10):4127. https:\/\/doi.org\/10.7150\/thno.97768.","journal-title":"Theranostics."},{"issue":"4","key":"2714_CR7","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S1470-2045(20)30754-3","volume":"22","author":"EP Winer","year":"2021","unstructured":"Winer EP, Lipatov O, Im S-A, Goncalves A, Mu\u00f1oz-Couselo E, Lee KS, Schmid P, Tamura K, Testa L, Witzel I. Pembrolizumab versus investigator-choice chemotherapy for metastatic triple-negative breast cancer (KEYNOTE-119): a randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(4):499\u2013511. https:\/\/doi.org\/10.1016\/S1470-2045(20)30754-3.","journal-title":"Lancet Oncol"},{"issue":"9","key":"2714_CR8","doi-asserted-by":"publisher","first-page":"e419","DOI":"10.1016\/S1470-2045(20)30234-5","volume":"21","author":"MO de Olza","year":"2020","unstructured":"de Olza MO, Rodrigo BN, Zimmermann S, Coukos G. Turning up the heat on non-immunoreactive tumours: opportunities for clinical development. Lancet Oncol. 2020;21(9):e419\u201330. https:\/\/doi.org\/10.1016\/S1470-2045(20)30234-5.","journal-title":"Lancet Oncol"},{"key":"2714_CR9","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jconrel.2022.02.020","volume":"344","author":"AS Widjaya","year":"2022","unstructured":"Widjaya AS, Liu Y, Yang Y, Yin W, Liang J, Jiang Y. Tumor-permeable smart liposomes by modulating the tumor microenvironment to improve the chemotherapy. J Control Release. 2022;344:62\u201379. https:\/\/doi.org\/10.1016\/j.jconrel.2022.02.020.","journal-title":"J Control Release"},{"key":"2714_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.120847","volume":"273","author":"J Liu","year":"2021","unstructured":"Liu J, Ai X, Cabral H, Liu J, Huang Y, Mi P. Tumor hypoxia-activated combinatorial nanomedicine triggers systemic antitumor immunity to effectively eradicate advanced breast cancer. Biomaterials. 2021;273: 120847. https:\/\/doi.org\/10.1016\/j.biomaterials.2021.120847.","journal-title":"Biomaterials"},{"issue":"20","key":"2714_CR11","doi-asserted-by":"publisher","first-page":"13226","DOI":"10.1021\/acsnano.4c02337","volume":"18","author":"J Li","year":"2024","unstructured":"Li J, Zhao Q, Zhang N, Wu L, Wang Q, Li J, Pan Q, Pu Y, Luo K, Gu Z. Triune nanomodulator enables exhausted cytotoxic T lymphocyte rejuvenation for cancer epigenetic immunotherapy. ACS Nano. 2024;18(20):13226\u201340. https:\/\/doi.org\/10.1021\/acsnano.4c02337.","journal-title":"ACS Nano"},{"issue":"6","key":"2714_CR12","doi-asserted-by":"publisher","first-page":"1804395","DOI":"10.1002\/adma.201804395","volume":"31","author":"T Ji","year":"2019","unstructured":"Ji T, Lang J, Ning B, Qi F, Wang H, Zhang Y, Zhao R, Yang X, Zhang L, Li W. Enhanced natural killer cell immunotherapy by rationally assembling Fc fragments of antibodies onto tumor membranes. Adv Mater. 2019;31(6):1804395. https:\/\/doi.org\/10.1002\/adma.201804395.","journal-title":"Adv Mater"},{"key":"2714_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.119795","volume":"235","author":"S Zhou","year":"2020","unstructured":"Zhou S, Huang Y, Chen Y, Liu S, Xu M, Jiang T, Song Q, Jiang G, Gu X, Gao X. Engineering ApoE3-incorporated biomimetic nanoparticle for efficient vaccine delivery to dendritic cells via macropinocytosis to enhance cancer immunotherapy. Biomaterials. 2020;235: 119795. https:\/\/doi.org\/10.1016\/j.biomaterials.2020.119795.","journal-title":"Biomaterials"},{"issue":"19","key":"2714_CR14","doi-asserted-by":"publisher","first-page":"2100794","DOI":"10.1002\/adhm.202100794","volume":"10","author":"YJ Li","year":"2021","unstructured":"Li YJ, Wu JY, Hu XB, Ding T, Tang T, Xiang DX. Biomimetic liposome with surface-bound elastase for enhanced tumor penetration and chemo-immumotherapy. Adv Healthc Mater. 2021;10(19):2100794. https:\/\/doi.org\/10.1002\/adhm.202100794.","journal-title":"Adv Healthc Mater."},{"key":"2714_CR15","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.jconrel.2021.04.029","volume":"334","author":"M Zhou","year":"2021","unstructured":"Zhou M, Luo C, Zhou Z, Li L, Huang Y. Improving anti-PD-L1 therapy in triple negative breast cancer by polymer-enhanced immunogenic cell death and CXCR4 blockade. J Control Release. 2021;334:248\u201362. https:\/\/doi.org\/10.1016\/j.jconrel.2021.04.029.","journal-title":"J Control Release"},{"issue":"4","key":"2714_CR16","doi-asserted-by":"publisher","first-page":"5184","DOI":"10.1021\/acsnano.2c01252","volume":"16","author":"AE Nel","year":"2022","unstructured":"Nel AE, Mei K-C, Liao Y-P, Liu X. Multifunctional lipid bilayer nanocarriers for cancer immunotherapy in heterogeneous tumor microenvironments, combining immunogenic cell death stimuli with immune modulatory drugs. ACS Nano. 2022;16(4):5184\u2013232. https:\/\/doi.org\/10.1021\/acsnano.2c01252.","journal-title":"ACS Nano"},{"key":"2714_CR17","doi-asserted-by":"publisher","first-page":"771201","DOI":"10.3389\/fimmu.2021.771201","volume":"12","author":"Y Ye","year":"2021","unstructured":"Ye Y, Xu C, Chen F, Liu Q, Cheng N. Targeting innate immunity in breast cancer therapy: a narrative review. Front Immunol. 2021;12:771201. https:\/\/doi.org\/10.3389\/fimmu.2021.771201.","journal-title":"Front Immunol"},{"issue":"5","key":"2714_CR18","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1172\/JCI31414","volume":"117","author":"AM Krieg","year":"2007","unstructured":"Krieg AM. Development of TLR9 agonists for cancer therapy. J Clin Invest. 2007;117(5):1184\u201394. https:\/\/doi.org\/10.1172\/JCI31414.","journal-title":"J Clin Invest"},{"issue":"6","key":"2714_CR19","doi-asserted-by":"publisher","first-page":"1801868","DOI":"10.1002\/advs.201801868","volume":"6","author":"C Deng","year":"2019","unstructured":"Deng C, Zhang Q, Jia M, Zhao J, Sun X, Gong T, Zhang Z. Tumors and their microenvironment dual-targeting chemotherapy with local immune adjuvant therapy for effective antitumor immunity against breast cancer. Adv Sci. 2019;6(6):1801868. https:\/\/doi.org\/10.1002\/advs.201801868.","journal-title":"Adv Sci"},{"issue":"7607","key":"2714_CR20","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nature18300","volume":"534","author":"LM Kranz","year":"2016","unstructured":"Kranz LM, Diken M, Haas H, Kreiter S, Loquai C, Reuter KC, Meng M, Fritz D, Vascotto F, Hefesha H. Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy. Nature. 2016;534(7607):396\u2013401. https:\/\/doi.org\/10.1038\/nature18300.","journal-title":"Nature"},{"issue":"1","key":"2714_CR21","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12951-022-01353-5","volume":"20","author":"B Deng","year":"2022","unstructured":"Deng B, Ma B, Ma Y, Cao P, Leng X, Huang P, Zhao Y, Ji T, Lu X, Liu L. Doxorubicin and CpG loaded liposomal spherical nucleic acid for enhanced Cancer treatment. J Nanobiotechnology. 2022;20(1):140. https:\/\/doi.org\/10.1186\/s12951-022-01353-5.","journal-title":"J Nanobiotechnology."},{"key":"2714_CR22","doi-asserted-by":"publisher","first-page":"120638","DOI":"10.1016\/j.biomaterials.2020.120638","volume":"269","author":"L Xie","year":"2021","unstructured":"Xie L, Wang G, Sang W, Li J, Zhang Z, Li W, Yan J, Zhao Q, Dai Y. Phenolic immunogenic cell death nanoinducer for sensitizing tumor to PD-1 checkpoint blockade immunotherapy. Biomaterials. 2021;269:120638. https:\/\/doi.org\/10.1016\/j.biomaterials.2020.120638.","journal-title":"Biomaterials"},{"issue":"3","key":"2714_CR23","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1021\/acsnano.8b08346","volume":"13","author":"W Yang","year":"2019","unstructured":"Yang W, Zhu G, Wang S, Yu G, Yang Z, Lin L, Zhou Z, Liu Y, Dai Y, Zhang F. In situ dendritic cell vaccine for effective cancer immunotherapy. ACS Nano. 2019;13(3):3083\u201394. https:\/\/doi.org\/10.1021\/acsnano.8b08346.","journal-title":"ACS Nano"},{"issue":"3","key":"2714_CR24","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41573-018-0006-z","volume":"18","author":"RS Riley","year":"2019","unstructured":"Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Disco. 2019;18(3):175\u201396. https:\/\/doi.org\/10.1038\/s41573-018-0006-z.","journal-title":"Nat Rev Drug Disco"},{"issue":"22","key":"2714_CR25","doi-asserted-by":"publisher","first-page":"12583","DOI":"10.1021\/acsomega.0c01592","volume":"5","author":"J Ahlawat","year":"2020","unstructured":"Ahlawat J, Guillama Barroso G, Masoudi Asil S, Alvarado M, Armendariz I, Bernal J, Carabaza X, Chavez S, Cruz P, Escalante V. Nanocarriers as potential drug delivery candidates for overcoming the blood\u2013brain barrier: challenges and possibilities. ACS Omega. 2020;5(22):12583\u201395. https:\/\/doi.org\/10.1021\/acsomega.0c01592.","journal-title":"ACS Omega"},{"key":"2714_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2021.102531","volume":"63","author":"Y Ji","year":"2021","unstructured":"Ji Y, Song S, Li X, Lv R, Wu L, Wang H, Cao M. Facile fabrication of nanocarriers with yolk-shell mesoporous silica nanoparticles for effective drug delivery. J Drug Deliv Sci Technol. 2021;63: 102531. https:\/\/doi.org\/10.1016\/j.jddst.2021.102531.","journal-title":"J Drug Deliv Sci Technol."},{"key":"2714_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmcr.2024.100202","author":"H Ahmadi","year":"2024","unstructured":"Ahmadi H, Heydari M, Abdouss M, Jamalpoor Z, Fathi-karkan S, Rahdar A, Pandey S. Metronidazole delivery strategies: optimizing cancer therapy through Novel approaches for enhanced delivery, cytotoxicity, and side effect reduction. Eur J Med Chem Rep. 2024. https:\/\/doi.org\/10.1016\/j.ejmcr.2024.100202.","journal-title":"Eur J Med Chem Rep"},{"issue":"4","key":"2714_CR28","doi-asserted-by":"publisher","first-page":"103936","DOI":"10.1016\/j.drudis.2024.103936","volume":"29","author":"SE Alavi","year":"2024","unstructured":"Alavi SE, Alharthi S, Alavi SF, Alavi SZ, Zahra GE, Raza A, Shahmabadi HE. Microfluidics for personalized drug delivery. Drug Discov Today. 2024;29(4):103936. https:\/\/doi.org\/10.1016\/j.drudis.2024.103936.","journal-title":"Drug Discov Today"},{"issue":"1","key":"2714_CR29","doi-asserted-by":"publisher","first-page":"103849","DOI":"10.1016\/j.drudis.2023.103849","volume":"29","author":"SE Alavi","year":"2024","unstructured":"Alavi SE, Alharthi S, Alavi SZ, Raza A, Shahmabadi HE. Bioresponsive drug delivery systems. Drug Discov Today. 2024;29(1):103849. https:\/\/doi.org\/10.1016\/j.drudis.2023.103849.","journal-title":"Drug Discov Today"},{"issue":"8","key":"2714_CR30","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1016\/j.drudis.2021.03.032","volume":"26","author":"SE Alavi","year":"2021","unstructured":"Alavi SE, Shahmabadi HE. GLP-1 peptide analogs for targeting pancreatic beta cells. Drug Discov Today. 2021;26(8):1936\u201343. https:\/\/doi.org\/10.1016\/j.drudis.2021.03.032.","journal-title":"Drug Discov Today"},{"key":"2714_CR31","doi-asserted-by":"publisher","first-page":"105436","DOI":"10.1016\/j.jddst.2024.105436","volume":"93","author":"SE Alavi","year":"2024","unstructured":"Alavi SE, Malik L, Matti R, Al-Najafi F, Shahmabadi HE, Sharma LA. Bioresponsive nanotechnology in pediatric dental drug delivery. J Drug Deliv Sci Technol. 2024;93:105436. https:\/\/doi.org\/10.1016\/j.jddst.2024.105436.","journal-title":"J Drug Deliv Sci Technol."},{"key":"2714_CR32","doi-asserted-by":"publisher","first-page":"5209","DOI":"10.2147\/IJN.S388075","volume":"17","author":"S Liu","year":"2022","unstructured":"Liu S, Li J, Gu L, Wu K, Xing H. Nanoparticles for chemoimmunotherapy against triple-negative breast cancer. Int J Nanomedicine. 2022;17:5209. https:\/\/doi.org\/10.2147\/IJN.S388075.","journal-title":"Int J Nanomedicine"},{"issue":"7","key":"2714_CR33","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1021\/acs.bioconjchem.0c00291","volume":"31","author":"SE Alavi","year":"2020","unstructured":"Alavi SE, Cabot PJ, Yap GY, Moyle PM. Optimized methods for the production and bioconjugation of site-specific, alkyne-modified glucagon-like peptide-1 (GLP-1) analogs to azide-modified delivery platforms using copper-catalyzed alkyne\u2013azide cycloaddition. Bioconjug Chem. 2020;31(7):1820\u201334. https:\/\/doi.org\/10.1021\/acs.bioconjchem.0c00291.","journal-title":"Bioconjug Chem"},{"key":"2714_CR34","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.ijbiomac.2021.06.014","volume":"184","author":"O Helmi","year":"2021","unstructured":"Helmi O, Elshishiny F, Mamdouh W. Targeted doxorubicin delivery and release within breast cancer environment using PEGylated chitosan nanoparticles labeled with monoclonal antibodies. Int J Biol Macromol. 2021;184:325\u201338. https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.06.014.","journal-title":"Int J Biol Macromol"},{"key":"2714_CR35","doi-asserted-by":"publisher","first-page":"131401","DOI":"10.1016\/j.colsurfa.2023.131401","volume":"668","author":"S Gao","year":"2023","unstructured":"Gao S, Lv R, Hao N, Wang H, Lv Y, Li Y, Ji Y, Liu Y. Fabrication of pH\/photothermal-responsive ZIF-8 nanocarriers loaded with baicalein for effective drug delivery and synergistic chem-photothermal effects. Colloids Surf A Physicochem Eng Asp. 2023;668:131401. https:\/\/doi.org\/10.1016\/j.colsurfa.2023.131401.","journal-title":"Colloids Surf A Physicochem Eng Asp"},{"issue":"4","key":"2714_CR36","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1021\/acs.bioconjchem.1c00091","volume":"32","author":"SE Alavi","year":"2021","unstructured":"Alavi SE, Cabot PJ, Raza A, Moyle PM. Developing GLP-1 conjugated self-assembling nanofibers using copper-catalyzed alkyne\u2013azide cycloaddition and evaluation of their biological activity. Bioconjug Chem. 2021;32(4):810\u201320. https:\/\/doi.org\/10.1021\/acs.bioconjchem.1c00091.","journal-title":"Bioconjug Chem"},{"issue":"4","key":"2714_CR37","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3390\/md15040096","volume":"15","author":"A Babu","year":"2017","unstructured":"Babu A, Ramesh R. Multifaceted applications of chitosan in cancer drug delivery and therapy. Mar Drugs. 2017;15(4):96. https:\/\/doi.org\/10.3390\/md15040096.","journal-title":"Mar Drugs"},{"issue":"44","key":"2714_CR38","doi-asserted-by":"publisher","first-page":"41485","DOI":"10.1021\/acsomega.3c05359","volume":"8","author":"SA Fahmy","year":"2023","unstructured":"Fahmy SA, Ramzy A, El Samaloty NM, Sedky NK, Azzazy HME-S. PEGylated chitosan nanoparticles loaded with betaine and nedaplatin hamper breast cancer: in vitro and in vivo studies. ACS omega. 2023;8(44):41485\u201394. https:\/\/doi.org\/10.1021\/acsomega.3c05359.","journal-title":"ACS omega."},{"key":"2714_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2021.131040","volume":"1245","author":"M Hassanpour","year":"2021","unstructured":"Hassanpour M, Jafari H, Sharifi S, Rezaie J, Lighvan ZM, Mahdavinia GR, Gohari G, Akbari A. Salicylic acid-loaded chitosan nanoparticles (SA\/CTS NPs) for breast cancer targeting: Synthesis, characterization and controlled release kinetics. J Mol Struct. 2021;1245: 131040. https:\/\/doi.org\/10.1016\/j.molstruc.2021.131040.","journal-title":"J Mol Struct"},{"issue":"10","key":"2714_CR40","doi-asserted-by":"publisher","first-page":"e20657","DOI":"10.1016\/j.heliyon.2023.e20657","volume":"9","author":"MB Parsa","year":"2023","unstructured":"Parsa MB, Tafvizi F, Chaleshi V, Ebadi M. Preparation, characterization, and Co-delivery of cisplatin and doxorubicin-loaded liposomes to enhance anticancer activities. Heliyon. 2023;9(10):e20657. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e20657.","journal-title":"Heliyon."},{"issue":"11","key":"2714_CR41","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.3390\/biom13111639","volume":"13","author":"NBT Le","year":"2023","unstructured":"Le NBT, Tu ATT, Zhao D, Yoshikawa C, Kawakami K, Kaizuka Y, Yamazaki T. Influence of the charge ratio of guanine\u2013quadruplex structure-based CpG oligodeoxynucleotides and cationic DOTAP liposomes on cytokine induction profiles. Biomolecules. 2023;13(11):1639. https:\/\/doi.org\/10.3390\/biom13111639.","journal-title":"Biomolecules"},{"issue":"6","key":"2714_CR42","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.22092\/ARI.2022.360447.2583","volume":"77","author":"M Taghizadeh","year":"2022","unstructured":"Taghizadeh M, Dabaghian M. Nasal administration of M2e\/CpG-ODN encapsulated in n-trimethyl chitosan (TMC) significantly increases specific immune responses in a mouse model. Arch Razi Inst. 2022;77(6):2259. https:\/\/doi.org\/10.22092\/ARI.2022.360447.2583.","journal-title":"Arch Razi Inst."},{"key":"2714_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2020.12.011","volume":"330","author":"YI Park","year":"2021","unstructured":"Park YI, Kwon S-H, Lee G, Motoyama K, Kim MW, Lin M, Niidome T, Choi JH, Lee R. pH-sensitive multi-drug liposomes targeting folate receptor \u03b2 for efficient treatment of non-small cell lung cancer. J Control Release. 2021;330:1\u201314. https:\/\/doi.org\/10.1016\/j.jconrel.2020.12.011.","journal-title":"J Control Release"},{"issue":"1","key":"2714_CR44","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/s0022-1759(98)00204-x","volume":"223","author":"MB Lutz","year":"1999","unstructured":"Lutz MB, Kukutsch N, Ogilvie AL, R\u00f6\u00dfner S, Koch F, Romani N, Schuler G. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods. 1999;223(1):77\u201392. https:\/\/doi.org\/10.1016\/s0022-1759(98)00204-x.","journal-title":"J Immunol Methods"},{"key":"2714_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2019.119649","volume":"230","author":"X Liu","year":"2020","unstructured":"Liu X, Feng Z, Wang C, Su Q, Song H, Zhang C, Huang P, Liang X-J, Dong A, Kong D. Co-localized delivery of nanomedicine and nanovaccine augments the postoperative cancer immunotherapy by amplifying T-cell responses. Biomaterials. 2020;230: 119649. https:\/\/doi.org\/10.1016\/j.biomaterials.2019.119649.","journal-title":"Biomaterials"},{"key":"2714_CR46","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jconrel.2019.02.035","volume":"300","author":"X Zhong","year":"2019","unstructured":"Zhong X, Zhang Y, Tan L, Zheng T, Hou Y, Hong X, Du G, Chen X, Zhang Y, Sun X. An aluminum adjuvant-integrated nano-MOF as antigen delivery system to induce strong humoral and cellular immune responses. J Control Release. 2019;300:81\u201392. https:\/\/doi.org\/10.1016\/j.jconrel.2019.02.035.","journal-title":"J Control Release"},{"key":"2714_CR47","doi-asserted-by":"publisher","first-page":"119464","DOI":"10.1016\/j.biomaterials.2019.119464","volume":"223","author":"L Luo","year":"2019","unstructured":"Luo L, Iqbal MZ, Liu C, Xing J, Akakuru OU, Fang Q, Li Z, Dai Y, Li A, Guan Y. Engineered nano-immunopotentiators efficiently promote cancer immunotherapy for inhibiting and preventing lung metastasis of melanoma. Biomaterials. 2019;223:119464. https:\/\/doi.org\/10.1016\/j.biomaterials.2019.119464.","journal-title":"Biomaterials"},{"issue":"11","key":"2714_CR48","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1016\/j.xphs.2022.06.002","volume":"111","author":"SE Alavi","year":"2022","unstructured":"Alavi SE, Raza A, Esfahani MKM, Akbarzadeh A, Abdollahi SH, Shahmabadi HE. Carboplatin niosomal nanoplatform for potentiated chemotherapy. J Pharm Sci. 2022;111(11):3029\u201337. https:\/\/doi.org\/10.1016\/j.xphs.2022.06.002.","journal-title":"J Pharm Sci"},{"key":"2714_CR49","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S377702","author":"F Gu","year":"2022","unstructured":"Gu F, Hu C, Cao W, Li C, Xia Q, Gao Y, Liu Y, Gao S. Tumor microenvironment multiple responsive nanoparticles for targeted delivery of doxorubicin and CpG against triple-negative breast cancer. Int J Nanomed. 2022. https:\/\/doi.org\/10.2147\/IJN.S377702.","journal-title":"Int J Nanomed"},{"key":"2714_CR50","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ijbiomac.2016.06.093","volume":"92","author":"MM Joseph","year":"2016","unstructured":"Joseph MM, Aswathy G, Manojkumar T, Sreelekha T. Galactoxyloglucan-doxorubicin nanoparticles exerts superior cytotoxic effects on cancer cells a mechanistic and in silico approach. Int J Biol Macromol. 2016;92:20\u20139. https:\/\/doi.org\/10.1016\/j.ijbiomac.2016.06.093.","journal-title":"Int J Biol Macromol"},{"issue":"7","key":"2714_CR51","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1002\/cmdc.201600029","volume":"11","author":"JB Nair","year":"2016","unstructured":"Nair JB, Joseph MM, Mohapatra S, Safeera M, Ghosh S, Sreelekha T, Maiti KK. A dual-targeting octaguanidine\u2013doxorubicin conjugate transporter for inducing caspase-mediated apoptosis on folate-expressing cancer cells. ChemMedChem. 2016;11(7):702\u201312. https:\/\/doi.org\/10.1002\/cmdc.201600029.","journal-title":"ChemMedChem"},{"key":"2714_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1208\/s12249-020-01742-9","volume":"21","author":"L Gautam","year":"2020","unstructured":"Gautam L, Sharma R, Shrivastava P, Vyas S, Vyas S. Development and characterization of biocompatible mannose functionalized mesospheres: an effective chemotherapeutic approach for lung cancer targeting. AAPS PharmSciTech. 2020;21:1\u201313. https:\/\/doi.org\/10.1208\/s12249-020-01742-9.","journal-title":"AAPS PharmSciTech"},{"key":"2714_CR53","doi-asserted-by":"publisher","first-page":"128337","DOI":"10.1016\/j.bmcl.2021.128337","volume":"50","author":"PS Uttekar","year":"2021","unstructured":"Uttekar PS, Yadav VD, Bhagwat DA. 1, 2-Dihexadecanoyl-sn-glycero-3-phosphoethanolamin (DPPE), doxorubicin and folic acid conjugated micelles for cancer management in tumor bearing BALB\/c mice. Bioorg Med Chem Lett. 2021;50:128337. https:\/\/doi.org\/10.1016\/j.bmcl.2021.128337.","journal-title":"Bioorg Med Chem Lett"},{"key":"2714_CR54","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.biomaterials.2019.01.001","volume":"197","author":"Z Jiang","year":"2019","unstructured":"Jiang Z, Wang Y, Sun L, Yuan B, Tian Y, Xiang L, Li Y, Li Y, Li J, Wu A. Dual ATP and pH responsive ZIF-90 nanosystem with favorable biocompatibility and facile post-modification improves therapeutic outcomes of triple negative breast cancer in vivo. Biomaterials. 2019;197:41\u201350. https:\/\/doi.org\/10.1016\/j.biomaterials.2019.01.001.","journal-title":"Biomaterials"},{"issue":"11","key":"2714_CR55","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.3390\/pharmaceutics14112256","volume":"14","author":"ER Gomes","year":"2022","unstructured":"Gomes ER, Souza FR, Cassali GD, Sabino AdP, Barros ALBd, Oliveira MC. Investigation of the antitumor activity and toxicity of tumor-derived exosomes fused with long-circulating and pH-sensitive liposomes containing doxorubicin. Pharmaceutics. 2022;14(11):2256. https:\/\/doi.org\/10.3390\/pharmaceutics14112256.","journal-title":"Pharmaceutics."},{"key":"2714_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.trac.2024.117672","author":"SS Marques","year":"2024","unstructured":"Marques SS, Segundo MA. Nanometrics goes beyond the size: Assessment of nanoparticle concentration and encapsulation efficiency in nanocarriers. Trends Analyt Chem. 2024. https:\/\/doi.org\/10.1016\/j.trac.2024.117672.","journal-title":"Trends Analyt Chem"},{"issue":"17","key":"2714_CR57","doi-asserted-by":"publisher","first-page":"9652","DOI":"10.3390\/ijms22179652","volume":"22","author":"V Miku\u0161ov\u00e1","year":"2021","unstructured":"Miku\u0161ov\u00e1 V, Miku\u0161 P. Advances in chitosan-based nanoparticles for drug delivery. Int J Mol Sci. 2021;22(17):9652. https:\/\/doi.org\/10.3390\/ijms22179652.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2714_CR58","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.3390\/molecules28041963","volume":"28","author":"K Jafernik","year":"2023","unstructured":"Jafernik K, \u0141adniak A, Blicharska E, Czarnek K, Ekiert H, Wi\u0105cek AE, Szopa A. Chitosan-based nanoparticles as effective drug delivery systems\u2014a review. Molecules. 2023;28(4):1963. https:\/\/doi.org\/10.3390\/molecules28041963.","journal-title":"Molecules"},{"key":"2714_CR59","doi-asserted-by":"publisher","first-page":"16023","DOI":"10.1038\/mtm.2016.23","volume":"3","author":"J Chen","year":"2016","unstructured":"Chen J, Guo Z, Tian H, Chen X. Production and clinical development of nanoparticles for gene delivery. Mol Ther Methods Clin Dev. 2016;3:16023. https:\/\/doi.org\/10.1038\/mtm.2016.23.","journal-title":"Mol Ther Methods Clin Dev."},{"issue":"2","key":"2714_CR60","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3390\/ijms21020559","volume":"21","author":"M Ghaferi","year":"2020","unstructured":"Ghaferi M, Asadollahzadeh MJ, Akbarzadeh A, Ebrahimi Shahmabadi H, Alavi SE. Enhanced efficacy of PEGylated liposomal cisplatin: In vitro and in vivo evaluation. Int J Mol Sci. 2020;21(2):559. https:\/\/doi.org\/10.3390\/ijms21020559.","journal-title":"Int J Mol Sci"},{"issue":"55","key":"2714_CR61","doi-asserted-by":"publisher","first-page":"31372","DOI":"10.1039\/c8ra05838e","volume":"8","author":"Y Jiao","year":"2018","unstructured":"Jiao Y, Li D, Liu C, Chang Y, Song J, Xiao Y. Polypeptide\u2013decorated nanoliposomes as novel delivery systems for lutein. RSC Adv. 2018;8(55):31372\u201381. https:\/\/doi.org\/10.1039\/c8ra05838e.","journal-title":"RSC Adv"},{"issue":"9","key":"2714_CR62","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.progpolymsci.2010.06.003","volume":"35","author":"ZL Tyrrell","year":"2010","unstructured":"Tyrrell ZL, Shen Y, Radosz M. Fabrication of micellar nanoparticles for drug delivery through the self-assembly of block copolymers. Prog Polym Sci. 2010;35(9):1128\u201343. https:\/\/doi.org\/10.1016\/j.progpolymsci.2010.06.003.","journal-title":"Prog Polym Sci"},{"issue":"24","key":"2714_CR63","doi-asserted-by":"publisher","first-page":"10748","DOI":"10.1039\/d1nr02065j","volume":"13","author":"L Shi","year":"2021","unstructured":"Shi L, Zhang J, Zhao M, Tang S, Cheng X, Zhang W, Li W, Liu X, Peng H, Wang Q. Effects of polyethylene glycol on the surface of nanoparticles for targeted drug delivery. Nanoscale. 2021;13(24):10748\u201364. https:\/\/doi.org\/10.1039\/d1nr02065j.","journal-title":"Nanoscale"},{"key":"2714_CR64","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.bioactmat.2022.02.025","volume":"15","author":"Y Li","year":"2022","unstructured":"Li Y, Zhang W, Zhao R, Zhang X. Advances in oral peptide drug nanoparticles for diabetes mellitus treatment. Bioact Mater. 2022;15:392\u2013408. https:\/\/doi.org\/10.1016\/j.bioactmat.2022.02.025.","journal-title":"Bioact Mater."},{"key":"2714_CR65","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jconrel.2024.03.036","volume":"369","author":"JJ Wilson","year":"2024","unstructured":"Wilson JJ, Bennie L, Eguaogie O, Elkashif A, Conlon PF, Jena L, McErlean E, Buckley N, Englert K, Dunne NJ. Synthesis and characterisation of a nucleotide based pro-drug formulated with a peptide into a nano-chemotherapy for colorectal cancer. J Control Release. 2024;369:63\u201374. https:\/\/doi.org\/10.1016\/j.jconrel.2024.03.036.","journal-title":"J Control Release"},{"issue":"27","key":"2714_CR66","doi-asserted-by":"publisher","first-page":"17353","DOI":"10.1021\/acsomega.1c01467","volume":"6","author":"M Ahamed","year":"2021","unstructured":"Ahamed M, Akhtar MJ, Khan MM, Alaizeri ZM, Alhadlaq H. Facile synthesis of Zn-doped Bi2O3 nanoparticles and their selective cytotoxicity toward cancer cells. ACS Omega. 2021;6(27):17353\u201361. https:\/\/doi.org\/10.1021\/acsomega.1c01467.","journal-title":"ACS Omega"},{"key":"2714_CR67","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S148359","author":"J Zhang","year":"2017","unstructured":"Zhang J, Tang H, Liu Z, Chen B. Effects of major parameters of nanoparticles on their physical and chemical properties and recent application of nanodrug delivery system in targeted chemotherapy. Int J Nanomed. 2017. https:\/\/doi.org\/10.2147\/IJN.S148359.","journal-title":"Int J Nanomed"},{"key":"2714_CR68","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1023\/a:1012128907225","volume":"14","author":"P Calvo","year":"1997","unstructured":"Calvo P, Remu\u00f1an-L\u00f3pez C, Vila-Jato JL, Alonso MJ. Chitosan and chitosan\/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines. Pharm Res. 1997;14:1431\u20136. https:\/\/doi.org\/10.1023\/a:1012128907225.","journal-title":"Pharm Res"},{"issue":"2","key":"2714_CR69","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3390\/pharmaceutics14020407","volume":"14","author":"SA Fahmy","year":"2022","unstructured":"Fahmy SA, Ramzy A, Mandour AA, Nasr S, Abdelnaser A, Bakowsky U, Azzazy HME-S. PEGylated chitosan nanoparticles encapsulating ascorbic acid and oxaliplatin exhibit dramatic apoptotic effects against breast cancer cells. Pharmaceutics. 2022;14(2):407. https:\/\/doi.org\/10.3390\/pharmaceutics14020407.","journal-title":"Pharmaceutics."},{"issue":"19","key":"2714_CR70","doi-asserted-by":"publisher","first-page":"5905","DOI":"10.3390\/molecules26195905","volume":"26","author":"S Adepu","year":"2021","unstructured":"Adepu S, Ramakrishna S. Controlled drug delivery systems: current status and future directions. Molecules. 2021;26(19):5905. https:\/\/doi.org\/10.3390\/molecules26195905.","journal-title":"Molecules"},{"issue":"7","key":"2714_CR71","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1691\/ph.2009.8374","volume":"64","author":"O Pinarbasli","year":"2009","unstructured":"Pinarbasli O, Aktas Y, Dalkara T, Andrieux K, Alonso M, Fernandez-Megia E, Novoa-Carballal R, Riguera R, Couvreur P, \u00c7apan Y. Preparation and evaluation of alpha-phenyl-n-tert-butyl nitrone (PBN)-encapsulated chitosan and PEGylated chitosan nanoparticles. Pharmazie. 2009;64(7):436\u20139. https:\/\/doi.org\/10.1691\/ph.2009.8374.","journal-title":"Pharmazie"},{"issue":"1\u20132","key":"2714_CR72","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.ijpharm.2012.04.004","volume":"430","author":"SA Papadimitriou","year":"2012","unstructured":"Papadimitriou SA, Achilias DS, Bikiaris DN. Chitosan-g-PEG nanoparticles ionically crosslinked with poly (glutamic acid) and tripolyphosphate as protein delivery systems. Int J Pharm. 2012;430(1\u20132):318\u201327. https:\/\/doi.org\/10.1016\/j.ijpharm.2012.04.004.","journal-title":"Int J Pharm"},{"key":"2714_CR73","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.addr.2021.01.019","volume":"174","author":"S Antimisiaris","year":"2021","unstructured":"Antimisiaris S, Marazioti A, Kannavou M, Natsaridis E, Gkartziou F, Kogkos G, Mourtas S. Overcoming barriers by local drug delivery with liposomes. Adv Drug Deliv Rev. 2021;174:53\u201386. https:\/\/doi.org\/10.1016\/j.addr.2021.01.019.","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"2714_CR74","doi-asserted-by":"publisher","first-page":"466","DOI":"10.3390\/pharmaceutics16040466","volume":"16","author":"G Zuccari","year":"2024","unstructured":"Zuccari G, Villa C, Iurilli V, Barabino P, Zorzoli A, Marimpietri D, Caviglia D, Russo E. Am Bisome\u00ae Formulations for Pediatrics: Stability, Cytotoxicity, and Cost-Effectiveness Studies. Pharmaceutics. 2024;16(4):466. https:\/\/doi.org\/10.3390\/pharmaceutics16040466.","journal-title":"Pharmaceutics"},{"key":"2714_CR75","first-page":"1","volume-title":"Nanotechnology for Hematology, Blood Transfusion, and Artificial Blood","author":"T Avsievich","year":"2022","unstructured":"Avsievich T, Zhu R, Popov A, Bykov A, Meglinski I. Blood\u2013nanomaterials interactions. In: Denizli A, Nguyen TA, Rajan M, Feroz Alam M, Rahman K, editors. Nanotechnology for Hematology, Blood Transfusion, and Artificial Blood. Elsevier; 2022. p. 1\u201340."},{"issue":"4","key":"2714_CR76","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1021\/acs.biomac.8b01704","volume":"20","author":"HR Phillips","year":"2019","unstructured":"Phillips HR, Tolstyka ZP, Hall BC, Hexum JK, Hackett PB, Reineke TM. Glycopolycation\u2013DNA polyplex formulation N\/P ratio affects stability, hemocompatibility, and in vivo biodistribution. Biomacromol. 2019;20(4):1530\u201344. https:\/\/doi.org\/10.1021\/acs.biomac.8b01704.","journal-title":"Biomacromol"},{"issue":"8","key":"2714_CR77","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1021\/nl0805615","volume":"8","author":"MA Dobrovolskaia","year":"2008","unstructured":"Dobrovolskaia MA, Clogston JD, Neun BW, Hall JB, Patri AK, McNeil SE. Method for analysis of nanoparticle hemolytic properties in vitro. Nano Lett. 2008;8(8):2180\u20137. https:\/\/doi.org\/10.1021\/nl0805615.","journal-title":"Nano Lett"},{"issue":"3","key":"2714_CR78","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1053\/j.seminoncol.2021.05.002","volume":"48","author":"MA Shah","year":"2021","unstructured":"Shah MA, Rogoff HA. Implications of reactive oxygen species on cancer formation and its treatment. Semin Oncol. 2021;48(3):238\u201345. https:\/\/doi.org\/10.1053\/j.seminoncol.2021.05.002.","journal-title":"Semin Oncol."},{"key":"2714_CR79","doi-asserted-by":"publisher","first-page":"131420","DOI":"10.1016\/j.cej.2021.131420","volume":"425","author":"L Shang","year":"2021","unstructured":"Shang L, Yang T, Yang C, Li Z, Kong L, Zhang Z. Metal ions-mediated self-assembly of nanomedicine for combinational therapy against triple-negative breast cancer. Chem Eng J. 2021;425:131420. https:\/\/doi.org\/10.1016\/j.cej.2021.131420.","journal-title":"Chem Eng J"},{"issue":"17","key":"2714_CR80","doi-asserted-by":"publisher","first-page":"3721","DOI":"10.1016\/j.vaccine.2024.04.086","volume":"42","author":"MLS P\u00e9rez","year":"2024","unstructured":"P\u00e9rez MLS, Montironi I, Funes JA, Margineda C, Campra N, Cariddi LN, Garrido JJ, Molina M, Alustiza F. Nanogel-Mediated antigen delivery: biocompatibility, immunogenicity, and potential for tailored vaccine design across species. Vaccine. 2024;42(17):3721\u201332. https:\/\/doi.org\/10.1016\/j.vaccine.2024.04.086.","journal-title":"Vaccine"},{"key":"2714_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2024.122666","volume":"311","author":"Y Li","year":"2024","unstructured":"Li Y, Rodriguez-Otero MR, Champion JA. Self-assembled protein vesicles as vaccine delivery platform to enhance antigen-specific immune responses. Biomaterials. 2024;311: 122666. https:\/\/doi.org\/10.1016\/j.biomaterials.2024.122666.","journal-title":"Biomaterials"},{"issue":"63","key":"2714_CR82","doi-asserted-by":"publisher","first-page":"39962","DOI":"10.1039\/C7RA06450K","volume":"7","author":"Y Han","year":"2017","unstructured":"Han Y, Duan Q, Li Y, Tian J. In vitro and in vivo investigation of chitosan\u2013polylysine polymeric nanoparticles for ovalbumin and CpG co-delivery. RSC Adv. 2017;7(63):39962\u20139. https:\/\/doi.org\/10.1039\/C7RA06450K.","journal-title":"RSC Adv"},{"issue":"6","key":"2714_CR83","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1021\/acs.molpharmaceut.9b00308","volume":"16","author":"SE Alavi","year":"2019","unstructured":"Alavi SE, Cabot PJ, Moyle PM. Glucagon-like peptide-1 receptor agonists and strategies to improve their efficiency. Mol Pharm. 2019;16(6):2278\u201395. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.9b00308.","journal-title":"Mol Pharm"},{"key":"2714_CR84","doi-asserted-by":"publisher","first-page":"111652","DOI":"10.1016\/j.eurpolymj.2022.111652","volume":"181","author":"SE Alavi","year":"2022","unstructured":"Alavi SE, Panah N, Page F, Gholami M, Dastfal A, Sharma LA, Shahmabadi HE. Hydrogel-based therapeutic coatings for dental implants. Eur Polym J. 2022;181:111652. https:\/\/doi.org\/10.1016\/j.eurpolymj.2022.111652.","journal-title":"Eur Polym J"},{"key":"2714_CR85","doi-asserted-by":"publisher","first-page":"118050","DOI":"10.1016\/j.carbpol.2021.118050","volume":"264","author":"X Li","year":"2021","unstructured":"Li X, Xing R, Xu C, Liu S, Qin Y, Li K, Yu H, Li P. Immunostimulatory effect of chitosan and quaternary chitosan: A review of potential vaccine adjuvants. Carbohydr Polym. 2021;264:118050. https:\/\/doi.org\/10.1016\/j.carbpol.2021.118050.","journal-title":"Carbohydr Polym"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02714-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-02714-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02714-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T01:59:07Z","timestamp":1746151147000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-02714-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,23]]},"references-count":85,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["2714"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-02714-4","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,23]]},"assertion":[{"value":"10 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"176"}}